Skip to main content
Have a personal or library account? Click to login
Transcatheter Mitral Valve Replacement in Failed Bioprosthetic Valve, Ring, and Mitral Annular Calcification Associated Mitral Valve Disease Using Balloon Expandable Transcatheter Heart Valve Cover

Transcatheter Mitral Valve Replacement in Failed Bioprosthetic Valve, Ring, and Mitral Annular Calcification Associated Mitral Valve Disease Using Balloon Expandable Transcatheter Heart Valve

Open Access
|May 2023

References

  1. Cheung A, Webb JG, Wong DR, et al. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009 Mar;87(3):e18-20. doi: 10.1016/j.athoracsur.2008.10.016
  2. Gammie JS, Chikwe J, Badhwar V, et al. Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. Ann Thorac Surg. 2018 Sep;106(3):716-727. doi: 10.1016/j.athoracsur.2018.03.086
  3. Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement. N Engl J Med. 2017 Nov 9;377(19):1847-1857. doi: 10.1056/NEJMoa1613792
  4. Mehaffey HJ, Hawkins RB, Schubert S, et al. Contemporary outcomes in reoperative mitral valve surgery. Heart. 2018 Apr;104(8):652-656. doi: 10.1136/heartjnl-2017-312047
  5. Kamioka N, Babaliaros V, Morse MA, et al. Comparison of Clinical and Echocardiographic Outcomes After Surgical Redo Mitral Valve Replacement and Transcatheter Mitral Valve-in-Valve Therapy. JACC Cardiovasc Interv. 2018 Jun 25;11(12):1131-1138. doi: 10.1016/j.jcin.2018.03.011
  6. Simonetto F, Purita PAM, Malerba M, et al. Surgical redo versus transseptal or transapical transcatheter mitral valve-in-valve implantation for failed mitral valve bioprosthesis. Catheter Cardiovasc Interv. 2021 Mar;97(4):714-722. doi: 10.1002/ccd.29324
  7. Zia Khan M, Zahid S, Khan MU, et al. Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve in Valve From the National Inpatient Sample. J Am Heart Assoc. 2021 Sep 7;10(17):e020948. doi: 10.1161/JAHA.121.020948
  8. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395
  9. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035
  10. Mack M, Carroll JD, Thourani V, et al. Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry. J Am Coll Cardiol. 2021 Dec 7;78(23):2326-2353. doi: 10.1016/j.jacc.2021.07.058
  11. Babaliaros VC, Lederman RJ, Gleason PT, et al. The Art of SAPIEN 3 Transcatheter Mitral Valve Replacement in Valve-in-Ring and Valve-in-Mitral-Annular-Calcification Procedures. JACC Cardiovasc Interv. 2021 Oct 25;14(20):2195-2214. doi: 10.1016/j.jcin.2021.08.044
  12. Kato N, Padang R, Scott CG, Guerrero M, Pislaru SV, Pellikka PA. The Natural History of Severe Calcific Mitral Stenosis. J Am Coll Cardiol. 2020 Jun 23;75(24):3048-3057. doi: 10.1016/j.jacc.2020.04.049
  13. Reddy YNV, Murgo JP, Nishimura RA. Complexity of Defining Severe “Stenosis” From Mitral Annular Calcification. Circulation. 2019 Aug 13;140(7):523-525. doi: 10.1161/CIRCULATIONAHA.119.040095
  14. Kato N, Guerrero M, Padang R, et al. Prevalence and Natural History of Mitral Annulus Calcification and Related Valve Dysfunction. Mayo Clin Proc. 2022 Jun;97(6):1094-1107. doi: 10.1016/j.mayocp.2021.12.015
  15. Tomšič A, Hiemstra YL, van Brakel TJ, et al. Outcomes of Valve Repair for Degenerative Disease in Patients With Mitral Annular Calcification. Ann Thorac Surg. 2019 Apr;107(4):1195-1201. doi: 10.1016/j.athoracsur.2018.08.017
  16. Blanke P, Naoum C, Webb J, et al. Multimodality Imaging in the Context of Transcatheter Mitral Valve Replacement: Establishing Consensus Among Modalities and Disciplines. JACC Cardiovasc Imaging. 2015 Oct;8(10):1191-1208. doi: 10.1016/j.jcmg.2015.08.004
  17. Guerrero M, Urena M, Himbert D, et al. 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. J Am Coll Cardiol. 2018 May 1;71(17):1841-1853. doi: 10.1016/j.jacc.2018.02.054
  18. Guerrero M, Wang DD, Eleid MF, et al. Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. JACC Cardiovasc Interv. 2021 Apr 26;14(8):830-845. doi: 10.1016/j.jcin.2021.01.052
  19. Guerrero M, Wang DD, Pursnani A, et al. Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. JACC Cardiovasc Interv. 2021 Apr 26;14(8):846-858. doi: 10.1016/j.jcin.2021.01.051
  20. Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019 Feb 1;40(5):441-451. doi: 10.1093/eurheartj/ehy590
  21. Urena M, Brochet E, Lecomte M, et al. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Eur Heart J. 2018 Jul 21;39(28):2679-2689. doi: 10.1093/eurheartj/ehy271
  22. Guerrero M, Pursnani A, Narang A, et al. Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes. JACC Cardiovasc Interv. 2021 Apr 26;14(8):859-872. doi: 10.1016/j.jcin.2021.02.027
  23. Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1220-1226. doi: 10.1002/ccd.26975
  24. Khan JM, Trivedi U, Gomes A, Lederman RJ, Hildick-Smith D. “Rescue” LAMPOON to Treat Transcatheter Mitral Valve Replacement-Associated Left Ventricular Outflow Tract Obstruction. JACC Cardiovasc Interv. 2019 Jul 8;12(13):1283-1284. doi: 10.1016/j.jcin.2018.12.026
  25. Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2020 Mar;13(3):e008425. doi: 10.1161/CIRCINTERVENTIONS.119.008425
  26. Bapat VV, Khaliel F, Ihleberg L. Delayed migration of Sapien valve following a transcatheter mitral valve-in-valve implantation. Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E150-4. doi: 10.1002/ccd.25076
  27. Nguyen A, Urena M, Himbert D, et al. Late Displacement After Transcatheter Mitral Valve Replacement for Degenerative Mitral Valve Disease With Massive Annular Calcification. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1633-4. doi: 10.1016/j.jcin.2016.05.033
  28. Pibarot P, Hahn RT, Weissman NJ, et al. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve. JAMA Cardiol. 2017 Nov 1;2(11):1208-1216. doi: 10.1001/jamacardio.2017.3425
  29. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007 Jan;93(1):137-42. doi: 10.1136/hrt.2005.071183
  30. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998 Dec;66(6 Suppl):S57-61. doi: 10.1016/s0003-4975(98)01110-2
  31. Garcia S, Fukui M, Dworak MW, et al. Clinical Impact of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2022 Mar;15(3):e011480. doi: 10.1161/CIRCINTERVENTIONS.121.011480
  32. Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017 Jun 17;389(10087):2383-2392. doi: 10.1016/S0140-6736(17)30757-2
  33. Korn D, DeSanctis RW, Sell S. Massive calcification of the mitral annulus. A clinicopathological study of fourteen cases. N Engl J Med. 1962 Nov 1;267:900-9. doi: 10.1056/NEJM196211012671802
  34. Guerrero M, Wang DD, Pursnani A, et al. A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. JACC Cardiovasc Imaging. 2020 Sep;13(9):1945-1957. doi: 10.1016/j.jcmg.2020.03.013
  35. Greenbaum AB, Perdoncin E, Paone G, et al. Tableside Skirt Modification of the SAPIEN 3 Valve to Reduce Paravalvular Leak During Transcatheter Mitral Valve Replacement. JACC Cardiovasc Interv. 2021 Apr 26;14(8):932-934. doi: 10.1016/j.jcin.2021.01.016
  36. Evin M, Guivier-Curien C, Rieu R, Rodés-Cabau J, Pibarot P. Mitral valve-in-valve hemodynamic performance: An in vitro study. J Thorac Cardiovasc Surg. 2016 Apr;151(4):1051-9.e6. doi: 10.1016/j.jtcvs.2015.11.039
  37. Greenbaum AB, Lisko JC, Gleason PT, et al. Annular-to-Apical «Emory Angle» to Ensure Coaxial Mitral Implantation of the SAPIEN 3 Valve. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2447-2450. doi: 10.1016/j.jcin.2020.07.024
  38. Urena M, Himbert D, Brochet E, et al. Transseptal Transcatheter Mitral Valve Replacement Using Balloon-Expandable Transcatheter Heart Valves: A Step-by-Step Approach. JACC Cardiovasc Interv. 2017 Oct 9;10(19):1905-1919. doi: 10.1016/j.jcin.2017.06.069
  39. Sabbagh AE, Al-Hijji M, Wang DD, et al. Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: An Analysis of the Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Global Registry. Circ Cardiovasc Interv. 2021 Oct;14(10):e010854. doi: 10.1161/CIRCINTERVENTIONS.121.010854
  40. Yoon SH, Bleiziffer S, Latib A, et al. Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. JACC Cardiovasc Interv. 2019 Jan 28;12(2):182-193. doi: 10.1016/j.jcin.2018.12.001
  41. Greenbaum AB, Condado JF, Eng M, et al. Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet. Catheter Cardiovasc Interv. 2018 Sep 1;92(3):627-632. doi: 10.1002/ccd.27054
  42. Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv. 2018 Aug 1;92(2):379-387. doi: 10.1002/ccd.27447
  43. Khan JM, Rogers T, Babaliaros VC, Fusari M, Greenbaum AB, Lederman RJ. Predicting Left Ventricular Outflow Tract Obstruction Despite Anterior Mitral Leaflet Resection: The «Skirt NeoLVOT». JACC Cardiovasc Imaging. 2018 Sep;11(9):1356-1359. doi: 10.1016/j.jcmg.2018.04.005
  44. Kohli K, Wei ZA, Sadri V, et al. Dynamic nature of the LVOT following transcatheter mitral valve replacement with LAMPOON: new insights from post-procedure imaging. Eur Heart J Cardiovasc Imaging. 2022 Apr 18;23(5):650-662. doi: 10.1093/ehjci/jeab074
  45. Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement. J Am Coll Cardiol. 2019 May 28;73(20):2521-2534. doi: 10.1016/j.jacc.2019.02.076
  46. Lisko JC, Greenbaum AB, Khan JM, et al. Antegrade Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction: A Simplified Technique From Bench to Bedside. Circ Cardiovasc Interv. 2020 Jun;13(6):e008903. doi: 10.1161/CIRCINTERVENTIONS.119.008903
  47. Wang DD, Guerrero M, Eng MH, et al. Alcohol Septal Ablation to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: First-in-Man Study. JACC Cardiovasc Interv. 2019 Jul 8;12(13):1268-1279. doi: 10.1016/j.jcin.2019.02.034
  48. Elhadi M, Guerrero M, Collins JD, Rihal CS, Eleid MF. Safety and Outcomes of Alcohol Septal Ablation Prior to Transcatheter Mitral Valve Replacement. J Soc Cardiovasc Angiogr Interv. 2022 Sep-Oct;1(5):100396. doi: 10.1016/j.jscai.2022.100396
  49. Killu AM, Collins JD, Eleid MF, et al. Preemptive Septal Radiofrequency Ablation to Prevent Left Ventricular Outflow Tract Obstruction With Transcatheter Mitral Valve Replacement: A Case Series. Circ Cardiovasc Interv. 2022 Oct;15(10):e012228. doi: 10.1161/CIRCINTERVENTIONS.122.012228
  50. Greenbaum AB, Khan JM, Bruce CG, et al. Transcatheter Myotomy to Treat Hypertrophic Cardiomyopathy and Enable Transcatheter Mitral Valve Replacement: First-in-Human Report of Septal Scoring Along the Midline Endocardium. Circ Cardiovasc Interv. 2022 Jun;15(6):e012106. doi: 10.1161/CIRCINTERVENTIONS.122.012106
  51. Whisenant B, Kapadia SR, Eleid MF, et al. One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. JAMA Cardiol. 2020 Nov 1;5(11):1245-1252. doi: 10.1001/jamacardio.2020.2974
  52. Simonato M, Whisenant B, Ribeiro HB, et al. Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Midterm Evaluation of Valve-in-Valve and Valve-in-Ring Implantation From the VIVID Registry. Circulation. 2021 Jan 12;143(2):104-116. doi: 10.1161/CIRCULATIONAHA.120.049088
  53. Eleid MF, Wang DD, Pursnani A, et al. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. J Am Coll Cardiol. 2022 Dec 6;80(23):2171-2183. doi: 10.1016/j.jacc.2022.09.037
  54. Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2020 Mar;13(3):e008425. doi: 10.1161/CIRCINTERVENTIONS.119.008425
  55. Eleid MF, Wang DD, Pursnani A, et al. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. J Am Coll Cardiol. 2022 Dec 6;80(23):2171-2183. doi: 10.1016/j.jacc.2022.09.037
DOI: https://doi.org/10.14797/mdcvj.1221 | Journal eISSN: 1947-6108
Language: English
Page range: 37 - 49
Submitted on: Feb 21, 2023
Accepted on: Apr 10, 2023
Published on: May 16, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2023 Hiroki A. Ueyama, Patrick T. Gleason, Vasilis C. Babaliaros, Adam B. Greenbaum, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.